Cite
HARVARD Citation
Santini, D. et al. (2019). How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials. Critical reviews in oncology/hematology. pp. 68-75. [Online].